What are people's thoughts on the recent news concerning Moderna/Merck's developments in work on their new skin cancer vaccine?
These mid-stage study results look promising and it will be interesting to see how things move forward into the phase 3 trials. Does this create a case for keeping a keen eye on this stock over the coming weeks/months?
More details here: [https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-mercks-skin-cancer-vaccine-shows-sustained-benefit-after-five-years-2026-01-20/](https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-mercks-skin-cancer-vaccine-shows-sustained-benefit-after-five-years-2026-01-20/)